Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 147 participants.

Also called NCT01493999

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 147 participants (enrolled count) (from the registry)
Sponsor
University of Pecs (from the registry)
Registry
  • NCT NCT01493999
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Hungary (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01493999. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2013-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity
Acronym
TREAT-HPR
Condition
Acute Coronary Syndrome
Intervention (Drug)
Clopidogrel reloading
Intervention (Drug)
Prasugrel
Lead sponsor
University of Pecs (class: other)

Record details

Record id
cardio:ct-nct01493999
Content hash
b04fd5056a9a6f4dbacdc3a507bb3424413db35b43dbe47d1635a43e338929fe